The Therapeutic Goods Administration is experiencing system issues linked to global Microsoft outages. Some services may be disrupted and we may take longer to respond to email and phone contact during this time.
OLMESARTAN MEDOXOMIL HCTZ GP, OLMESARTAN HCT GPPL, OLMESART HCT GXP, OLMESART HCT (Generic Partners Pty Ltd)
Product name
OLMESARTAN MEDOXOMIL HCTZ GP, OLMESARTAN HCT GPPL, OLMESART HCT GXP, OLMESART HCT
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
142 working days (255)
Active ingredients
olmesartan medoxomil & hydrochlorothiazide
Registration type
New generic medicine
Indication
OLMESARTAN MEDOXOMIL HCTZ GP, OLMESARTAN HCT GPPL, OLMESART HCT GXP, OLMESART HCT (tablets) is indicated for the treatment of hypertension. Treatment should not be initiated with this fixed dose combination.